295 related articles for article (PubMed ID: 30989085)
1. Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis.
Carias KV; Wevrick R
Mol Ther Methods Clin Dev; 2019 Jun; 13():344-358. PubMed ID: 30989085
[TBL] [Abstract][Full Text] [Related]
2. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.
Cheon CK
Ann Pediatr Endocrinol Metab; 2016 Sep; 21(3):126-135. PubMed ID: 27777904
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
5. Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.
Griggs JL; Su XQ; Mathai ML
N Am J Med Sci; 2015 Nov; 7(11):509-16. PubMed ID: 26713299
[TBL] [Abstract][Full Text] [Related]
6. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome.
Costa RA; Ferreira IR; Cintra HA; Gomes LHF; Guida LDC
Front Endocrinol (Lausanne); 2019; 10():864. PubMed ID: 31920975
[TBL] [Abstract][Full Text] [Related]
8. Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome.
Bischof JM; Wevrick R
Mol Genet Metab; 2018 Apr; 123(4):511-517. PubMed ID: 29506955
[TBL] [Abstract][Full Text] [Related]
9. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
10. High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome.
Beauloye V; Diene G; Kuppens R; Zech F; Winandy C; Molinas C; Faye S; Kieffer I; Beckers D; Nergårdh R; Hauffa B; Derycke C; Delhanty P; Hokken-Koelega A; Tauber M
Orphanet J Rare Dis; 2016 May; 11(1):56. PubMed ID: 27146407
[TBL] [Abstract][Full Text] [Related]
11. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
12. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
13. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
14. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome: A model for understanding the ghrelin system.
Tauber M; Coupaye M; Diene G; Molinas C; Valette M; Beauloye V
J Neuroendocrinol; 2019 Jul; 31(7):e12728. PubMed ID: 31046160
[TBL] [Abstract][Full Text] [Related]
16. Behavioural and cognitive profiles of mouse models for Prader-Willi syndrome.
Relkovic D; Isles AR
Brain Res Bull; 2013 Mar; 92():41-8. PubMed ID: 21971015
[TBL] [Abstract][Full Text] [Related]
17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
18. Review of Prader-Willi syndrome: the endocrine approach.
Heksch R; Kamboj M; Anglin K; Obrynba K
Transl Pediatr; 2017 Oct; 6(4):274-285. PubMed ID: 29184809
[TBL] [Abstract][Full Text] [Related]
19. ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison.
Barclay SF; Rand CM; Nguyen L; Wilson RJA; Wevrick R; Gibson WT; Bech-Hansen NT; Weese-Mayer DE
Orphanet J Rare Dis; 2018 Jul; 13(1):124. PubMed ID: 30029683
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics.
Spikol ED; Laverriere CE; Robnett M; Carter G; Wolfe EM; Glasgow E
Diseases; 2016 Mar; 4(1):. PubMed ID: 27857842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
